Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix, Inc. 34 Crosby Drive Suite 105 Bedford, MA 01730 United States Phone: 781-357-4000 Fax: 781-357-4001 Website: http://www.ocutx.com Watchlist 26.27 Up 4.31(19.63%) May 15, 4:00PM EDT Add to Portfolio Profile Get Profile for: Ocular Therapeutix, Inc. 34 Crosby Drive Suite 105 Bedford, MA 01730 United States - Map Phone: 781-357-4000 Fax: 781-357-4001 Website: http://www.ocutx.com Details Index Membership: N/A Sector: Healthcare Industry: Biotechnology Full Time Employees: 74 Business Summary Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for eye diseases and conditions using its proprietary hydrogel platform technology in the United States. It markets ReSure Sealant, a topical liquid hydrogel that creates a sealant to prevent post-surgical leakage from clear corneal incisions during cataract surgery. The company is involved in developing OTX-DP that is in Phase III clinical trials for post-surgical ocular inflammation and pain; and is in Phase II clinical trials for the treatment of inflammatory dry eye disease, as well as that has completed Phase II clinical trials for the treatment of allergic conjunctivitis. It is also developing OTX-TP, which is in Phase IIb clinical trials for glaucoma and ocular hypertension; OTX-MP product candidate that has completed Phase I clinical trials for the treatment of ocular infection indication; and Anti-VEGF hydrogel depot, an injectable hydrogel depot that is in preclinical studies. Ocular Therapeutix, Inc. was founded in 2006 and is headquartered in Bedford, Massachusetts.